Skip to main content
. 2023 Nov 6;55(2):2241013. doi: 10.1080/07853890.2023.2241013

Figure 4.

Figure 4.

The ROC curve for the early recurrence and metastasis group and the non-recurrence and metastasis group. A. The area under the ROC curve was 0.917, p < 0.001. B. Prognostic index in the initial sample group and progression-free survival in patients with lung adenocarcinoma, p < 0.001. C. Prognostic index in the validation sample group and progression-free survival in patients with lung adenocarcinoma, p < 0.001.